This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Heide Reil
Introduction
Heide Reil is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of viral vector systems, particularly in the development of infectious pseudotyped lentiviral vectors. His work has implications for various applications in gene therapy and vaccine development.
Latest Patents
Heide Reil holds a patent for "Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof." This patent describes vector systems that encode viral proteins capable of assembling into an infectious lentivirus particle with a deletion of the lentiviral matrix. In one embodiment, the vectors encode a lentiviral envelope protein that contains a deletion of the cytoplasmic tail. In another embodiment, a heterologous envelope is utilized, which targets an endocytic compartment.
Career Highlights
Heide Reil is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in the field of cancer and viral vectors. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
He has collaborated with esteemed colleagues such as Heinrich Göttlinger and Anatoly Bukovsky, contributing to a rich exchange of ideas and advancements in their shared field of research.
Conclusion
Heide Reil's contributions to the field of viral vector systems exemplify the importance of innovation in medical research. His patent and ongoing work at the Dana-Farber Cancer Institute Inc. highlight his role in advancing therapeutic technologies.